Senior insider sale
General Counsel at CENTESSA PHARMACEUTICALS PLC — senior position signals high conviction
$1.27M
58K shares
What this filing means
HUSSAIN IQBAL J plans to sell 58K shares of CENTESSA PHARMACEUTICALS PLC valued at approximately $1.27M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/17/2025ACC: 0001969223-25-000957
Officer· General Counsel
Since May 2021
58K
Shares to sell
$1.27M
Approx. market value
6K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
11/17/2025
6KTotal acquired6K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/17/2025 | Exercise of Stock Options Cash | 6K | — |
| Total | 6K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
6K
Market value
$134.4K
10/15/2025
—Completed
Units to sell
6K
Market value
$131.1K
9/15/2025
—Completed
Units to sell
20K
Market value
$440.0K
9/10/2025
—Completed
Units to sell
20K
Market value
$400.1K
9/9/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
6K
Market value
$166.4K
11/17/2025
Total
Units
58K
Value
$1.27M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/15/2025 | 6K | $134.4K | — | Completed |
9/15/2025 | 6K | $131.1K | — | Completed |
9/10/2025 | 20K | $440.0K | — | Completed |
9/9/2025 | 20K | $400.1K | — | Completed |
| Planned — Approximate Date | ||||
11/17/2025 | 6K | $166.4K | Nasdaq | Planned |
| Total | 58K | $1.27M | ||